LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Liu, W B ^a   Jiang, X ^a   Han, F ^a   Li, Y H ^a   Chen, H Q ^a   Liu, Y ^a   Cao, J ^a   Liu, J Y ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Epigenetics; LHX6; Lung cancer; Tumour suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; CYCLIN D1; HERMES ANTIGEN; MATRILYSIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LHX6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; DRUG CYTOTOXICITY; FEMALE; GENE INACTIVATION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; APOPTOSIS; AZACITIDINE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; LIM-HOMEODOMAIN PROTEINS; LUNG NEOPLASMS; MICE; MICE, NUDE; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING;

EID: 84887449338     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.366     Document Type: Article

References (46)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Mascaux C, Peled N, Garg K, Kato Y, Wynes MW, Hirsch FR. Early detection and screening of lung cancer. Expert Rev Mol Diagn 2010; 10: 799-815.
3. Breuer RH, Pasic A, Smit EF, van Vliet E, Vonk Noordegraaf A, Risse EJ et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 2005; 11: 537-543.
4. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642.
5. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8: 286-298.
6. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008; 123: 1-7.
7. Feil R, Fraga MF. Epigenetics and the environment: Emerging patterns and implications. Nat Rev Genet 2012; 13: 97-109.
8. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17: 330-339.
9. Cui T, Chen Y, Yang L, Knösel T, Huber O, Pacyna-Gengelbach M et al. The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer. Carcinogenesis 2012; 33: 2326-2333.
10. Jia Y, Yang Y, Brock MV, Zhan Q, Herman JG, Guo M. Epigenetic regulation of DACT2, A key component of the Wnt signaling pathway in human lung cancer. J Pathol 2013; 230: 194-204.
11. Yang L, Chen Y, Cui T, Knösel T, Zhang Q, Albring KF et al. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/b-catenin signaling pathway in human lung cancer. Carcinogenesis 2012; 33: 1863-1870.
12. Liu W, Li X, Chu ES, Go MY, Xu L, Zhao G et al. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology 2011; 53: 843-853.
13. Xu L, Li X, Chu ES, Zhao G, Go MY, Tao Q et al. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival of gastric cancer. Gut 2012; 61: 977-985.
14. Grigoriou M, Tucker AS, Sharpe PT, Pachnis V. Expression and regulation of Lhx6 and Lhx7, a novel subfamily of LIM homeodomain encoding genes, suggests a role in mammalian head development. Development 1998; 125: 2063-2074.
15. Liodis P, Denaxa M, Grigoriou M, Akufo-Addo C, Yanagawa Y, Pachnis V. Lhx6 activity is required for the normal migration and specification of cortical interneuron subtypes. J Neurosci 2007; 27: 3078-3089.
16. Flandin P, Zhao Y, Vogt D, Jeong J, Long J, Potter G et al. Lhx6 and Lhx8 coordinately induce neuronal expression of Shh that controls the generation of interneuron progenitors. Neuron 2011; 70: 939-950.
17. Esté cio MR, Youssef EM, Rahal P, Fukuyama EE, Gó is-Filho JF, Maniglia JV et al. LHX6 is a sensitive methylation marker in head and neck carcinomas. Oncogene 2006; 25: 5018-5026.
18. Jung S, Jeong D, Kim J, Yi L, Koo K, Lee J et al. The role of hLHX6-HMR as a methylation biomarker for early diagnosis of cervical cancer. Oncol Rep 2010; 23: 1675-1682.
19. Jung S, Jeong D, Kim J, Yi L, Koo K, Lee J et al. Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer. Int J Oncol 2011; 38: 859-869.
20. Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
21. Okamoto J, Hirata T, Chen Z, Zhou HM, Mikami I, Li H et al. EMX2 is epigenetically silenced and suppresses growth in human lung cancer. Oncogene 2010; 29: 5969-5975.
22. Liu Y, An Q, Li L, Zhang D, Huang J, Feng X et al. Hypermethylation of p16INK4a in Chinese lung cancer patients: Biological and clinical implications. Carcinogenesis 2003; 24: 1897-1901.
23. Tessema M, Klinge DM, Yingling CM, Do K, Van Neste L, Belinsky SA. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogene 2010; 29: 5159-5170.
24. Yaden BC, MIII Garcia, Smith TP, Rhodes SJ. Two promoters mediate transcription from the human LHX3 gene: Involvement of nuclear factor I and specificity protein 1. Endocrinology 2006; 147: 324-337.
25. Hung TM, Hu RH, Ho CM, Chiu YL, Lee JL, Jeng YM et al. Downregulation of alphafetoprotein expression by LHX4: A critical role in hepatocarcinogenesis. Carcinogenesis 2011; 32: 1815-1823.
26. Choi Y, Ballow DJ, Xin Y, Rajkovic A. Lim homeobox gene, lhx8, is essential for mouse oocyte differentiation and survival. Biol Reprod 2008; 79: 442-449.
27. Vladimirova V, Mikeska T, Waha A, Soerensen N, Xu J, Reynolds PC et al. Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood. Neoplasia 2009; 11: 700-711.
28. Dong W, Feng L, Xie Y, Zhang H, Wu Y. Hypermethylation-mediated reduction of LMX1A expression in gastric cancer. Cancer Sci 2011; 102: 361-366.
29. Chao TK, Yo YT, Liao YP, Wang YC, Su PH, Huang TS et al. LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer. Gynecol Oncol 2013; 128: 475-482.
30. Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP,Wouters KA et al. N-Myc downstream-regulated gene 4 (NDRG4): A candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 2009; 101: 916-927.
31. Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S et al. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. Oncogene 2010; 29: 6464-6474.
32. Das PM, Thor AD, Edgerton SM, Barry SK, Chen DF, Jones FE. Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene 2010; 29: 5214-5219.
33. Du W, Wang S, Zhou Q, Li X, Chu J, Chang Z et al. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene 2013; 32: 3319-3328.
34. Cheung KF, Lam CN, Wu K, Ng EK, Chong WW, Cheng AS et al. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer. Cancer 2012; 118: 947-959.
35. Xu X, Liu RF, Wan BB, Xing WM, Huang J, Han ZG. Expression of a novel gene FAM43B repressing cell proliferation is regulated by DNA methylation in hepatocellular carcinoma cell lines. Mol Cell Biochem 2011; 354: 11-20.
36. Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T et al. Identification of a Wnt/b-Catenin-Pitx2 pathway mediating cell-Type-specific proliferation during development. Cell 2011; 111: 673-685.
37. Zhang Z, Gutierrez D, Li X, Bidlack F, Cao H, Wang J et al. The LIM Homeodomain Transcription Factor LHX6: A transcriptional repressor that interacts with Pituitary homeobox 2 (PITX2) to regulate odontogenesis. J Biol Chem 2013; 288: 2485-2500.
38. Vadlamudi U, Espinoza HM, Ganga M, Martin DM, Liu X, Engelhardt JF et al. PITX2, betacatenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci 2000; 118: 1129-1137.
39. Baek SH, Kioussi C, Briata P, Wang D, Nguyen HD, Ohgi KA et al. Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 2003; 100: 3245-3250.
40. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-1851.
41. Liu WB, Han F, Jiang X, Yang LJ, Li YH, Liu Y et al. ANKRD18A as a novel epigenetic regulation gene in lung cancer. Biochem Biophys Res Commun 2012; 429: 180-185.
42. Liu WB, Liu JY, Ao L, Zhou ZY, Zhou YH, Cui ZH et al. Dynamic changes in DNA methylation during multistep rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine. Toxicol Lett 2009; 189: 5-13.
43. Liu WB, Liu JY, Ao L, Zhou ZY, Zhou YH, Cui ZH et al. Epigenetic silencing of cell cycle regulatory genes during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung cancer. Mol Carcinog 2010; 49: 556-565.
44. Liu WB, Ao L, Zhou ZY, Cui ZH, Zhou YH, Yuan XY et al. CpG island hypermethylation of multiple tumor suppressor genes associated with loss of their protein expression during rat lung carcinogenesis induced by 3-methylcholanthrene and diethylnitrosamine. Biochem Biophys Res Commun 2010; 402: 507-514.
45. Liu WB, Ao L, Cui ZH, Zhou ZY, Zhou YH, Yuan XY et al. Molecular analysis of DNA repair gene methylation and protein expression during chemical-induced rat lung carcinogenesis. Biochem Biophys Res Commun 2011; 408: 596-601.
46. Liu WB, Cui ZH, Ao L, Zhou ZY, Zhou YH, Yuan XY et al. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a. Toxicol Appl Pharmacol 2011; 251: 70-78